| Bacteriophage endolysins as a novel class of antibacterial agents J Borysowski, B Weber-Dąbrowska, A Górski Experimental biology and medicine 231 (4), 366-377, 2006 | 517 | 2006 |
| Clinical aspects of phage therapy R Międzybrodzki, J Borysowski, B Weber-Dąbrowska, W Fortuna, ... Advances in virus research 83, 73-121, 2012 | 452 | 2012 |
| Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. S Slopek, B Weber-Dabrowska, M Dabrowski, A Kucharewicz-Krukowska Archivum immunologiae et therapiae experimentalis 35 (5), 569-583, 1987 | 402 | 1987 |
| Bacteriophage penetration in vertebrates K Dabrowska, K Switała‐Jelen, A Opolski, B Weber‐Dabrowska, A Gorski Journal of applied microbiology 98 (1), 7-13, 2005 | 341 | 2005 |
| Bacteriophage therapy of bacterial infections: an update of our institute’s experience B Weber-Dąbrowska, M Mulczyk, A Górski Inflammation, 201-209, 2001 | 326 | 2001 |
| Phage as a modulator of immune responses: practical implications for phage therapy A Górski, R Międzybrodzki, J Borysowski, K Dąbrowska, P Wierzbicki, ... Advances in virus research 83, 41-71, 2012 | 297 | 2012 |
| Bacteriophage translocation A Górski, E Ważna, BW Dąbrowska, K Dąbrowska, K Świtała-Jeleń, ... FEMS Immunology & Medical Microbiology 46 (3), 313-319, 2006 | 286 | 2006 |
| Phage neutralization by sera of patients receiving phage therapy M Łusiak-Szelachowska, M Żaczek, B Weber-Dąbrowska, ... Viral immunology 27 (6), 295-304, 2014 | 243 | 2014 |
| The potential role of endogenous bacteriophages in controlling invading pathogens A Górski, B Weber-Dabrowska Cellular and molecular life sciences 62 (5), 511-519, 2005 | 227 | 2005 |
| Bacteriophage procurement for therapeutic purposes B Weber-Dąbrowska, E Jończyk-Matysiak, M Żaczek, M Łobocka, ... Frontiers in microbiology 7, 1177, 2016 | 208 | 2016 |
| Bacteriophage therapy for the treatment of infections. A Gorski, R Miedzybrodzki, J Borysowski, B Weber-Dabrowska, ... Current opinion in investigational drugs (London, England: 2000) 10 (8), 766-774, 2009 | 195 | 2009 |
| Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases A Górski, R Międzybrodzki, B Weber-Dąbrowska, W Fortuna, S Letkiewicz, ... Frontiers in microbiology 7, 1515, 2016 | 176 | 2016 |
| Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results S Slopek, I Durlakowa, B Weber-Dabrowska, A Kucharewicz-Krukowska, ... Arch. Immunol. Ther. Exp 31 (3), 267-291, 1983 | 175 | 1983 |
| Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae A Kęsik-Szeloch, Z Drulis-Kawa, B Weber-Dąbrowska, J Kassner, ... Virology journal 10, 1-12, 2013 | 164 | 2013 |
| Phages and immunomodulation A Górski, K Dąbrowska, R Międzybrodzki, B Weber-Dąbrowska, ... Future microbiology 12 (10), 905-914, 2017 | 162 | 2017 |
| Studies on bacteriophage penetration in patients subjected to phage therapy B Weber-Dabrowska, M Dabrowski, S Slopek Archivum immunologiae et therapiae experimentalis 35 (5), 563-568, 1987 | 159 | 1987 |
| Preparation of endotoxin-free bacteriophages J Boratyński, D Syper, B Weber-Dabrowska, M Łusiak-Szelachowska, ... Cell Mol Biol Lett 9 (2), 253-9, 2004 | 152 | 2004 |
| Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man B Weber-Dabrowska, M Mulczyk, A Górski Transplantation proceedings 35 (4), 1385-1386, 2003 | 151 | 2003 |
| Phage therapy: Current status and perspectives A Górski, R Międzybrodzki, G Węgrzyn, E Jończyk‐Matysiak, ... Medicinal research reviews 40 (1), 459-463, 2020 | 144 | 2020 |
| Phage therapy: what have we learned? A Górski, R Międzybrodzki, M Łobocka, A Głowacka-Rutkowska, ... Viruses 10 (6), 288, 2018 | 141 | 2018 |